Activation of FGF Receptors is a new Mechanism by which Strontium Ranelate Induces Osteoblastic Cell Growth
Authors:
- Joseph CaverzasioJCJoseph Caverzasio
- Cyril ThouvereyCTCyril Thouverey
- 1 January 2011
- journal article
- Published by S. Karger AG in Cellular Physiology and Biochemistry
- Vol. 27 (3-4) , 243-250
Abstract
Strontium ranelate (SrRan) is an anti-osteoporotic treatment that reduces the risk of vertebral and hip fractures. Recent in vitro studies suggest that the effect of strontium ranelate on osteoblastic cell growth likely involves two processes including activation of the calcium sensing receptor (CaSR) and a yet undefined mechanism. In the present study, we investigated the CaSR-independent molecular mechanism by which SrRan stimulates osteoblast growth. MC3T3-E1 and primary osteoblastic cells, specific inhibitors of receptor tyrosine kinases (RTK) and western blot analysis were used to characterize the CaSR-independent mechanism in osteoblastic cells. A selective inhibitor of FGF receptor but not other RTK inhibitors markedly blunted cell growth induced by SrRan in osteoblastic cells. Associated with this observation, SrRan induced rapid activation of FGFR signaling pathways such as PLCγ, FRS2, Akt, ERK1,2 and p38. FGFR-dependent stimulation of osteogenic cell growth was also observed with other cations but not with neomycin, a selective CaSR agonist. Also, in cultured conditions used in this study, MC3T3-E1 cells and primary osteoblasts did not express the CaSR. data presented in this study suggest that activation of FGFRs is a new potential mechanism by which strontium can stimulate osteoblastic cell growth. Activation of FGFR-dependent cell growth is also observed in response to other cations suggesting that activation of FGF receptors is a new cation sensing mechanism in osteoblasts.Keywords
This publication has 30 references indexed in Scilit:
- Calcium sensing receptor‐dependent and receptor‐independent activation of osteoblast replication and survival by strontium ranelateJournal of Cellular and Molecular Medicine, 2009
- The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferationBiochemical Pharmacology, 2007
- Induction of a program gene expression during osteoblast differentiation with strontium ranelateBiochemical and Biophysical Research Communications, 2007
- FGF and FGFR signaling in chondrodysplasias and craniosynostosisJournal of Cellular Biochemistry, 2005
- In vitro effects of strontium ranelate on the extracellular calcium-sensing receptorBiochemical and Biophysical Research Communications, 2004
- Differential regulation of platelet‐derived growth factor stimulated migration and proliferation in osteoblastic cellsJournal of Cellular Biochemistry, 2004
- Le ranélate de strontium, nouvel agent thérapeutique dans l’ostéoporose post-ménopausiquemédecine/sciences, 2004
- Protein Kinase C-independent Activation of Protein Kinase D Is Involved in BMP-2-induced Activation of Stress Mitogen-activated Protein Kinases JNK and p38 and Osteoblastic Cell DifferentiationJournal of Biological Chemistry, 2004
- Mesenchymal Cells Potentiate Vascular Endothelial Growth Factor-Induced AngiogenesisExperimental Cell Research, 2002
- Copper and Calcium Binding Motifs in the Extracellular Domains of Fibroblast Growth Factor ReceptorsJournal of Biological Chemistry, 1996